85 related articles for article (PubMed ID: 32826307)
21. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
22. Letter to the editor: Postvaccination COVID-19-related mortality in patients with cirrhosis: Who is the culprit?
Duan Z
Hepatology; 2023 Jan; 77(1):E13. PubMed ID: 36065521
[No Abstract] [Full Text] [Related]
23. Hepatic manifestations and impact of COVID-19 on the cirrhotic patient.
Velarde-Ruiz Velasco JA; García-Jiménez ES; Remes-Troche JM
Rev Gastroenterol Mex (Engl Ed); 2020; 85(3):303-311. PubMed ID: 32553772
[TBL] [Abstract][Full Text] [Related]
24. Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes.
Liu F; Long X; Ji G; Zhang B; Zhang W; Zhang Z; Chen X
J Infect; 2020 Aug; 81(2):e178-e180. PubMed ID: 32562796
[No Abstract] [Full Text] [Related]
25. Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chronic Liver Failure in the COVID-19 Era.
Premkumar M; Kajal K; Kulkarni AV; Gupta A; Divyaveer S
J Intensive Care Med; 2021 May; 36(5):511-523. PubMed ID: 33438491
[TBL] [Abstract][Full Text] [Related]
26. The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC).
Kim DJ; Jeong WI; Tsukamoto H; Gao B
Clin Mol Hepatol; 2020 Oct; 26(4):584-585. PubMed ID: 33053933
[No Abstract] [Full Text] [Related]
27. Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19).
Lopez-Mendez I; Aquino-Matus J; Gall SM; Prieto-Nava JD; Juarez-Hernandez E; Uribe M; Castro-Narro G
Ann Hepatol; 2021; 20():100271. PubMed ID: 33099028
[TBL] [Abstract][Full Text] [Related]
28. Let's not forget our COVID-19-free cirrhotic patients!
Viganò M; Carbone M
Liver Int; 2020 Jun; 40(6):1508-1509. PubMed ID: 32329551
[No Abstract] [Full Text] [Related]
29. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study.
Liu R; Zhao L; Cheng X; Han H; Li C; Li D; Liu A; Gao G; Zhou F; Liu F; Jiang Y; Zhu C; Xia Y
Liver Int; 2021 Apr; 41(4):720-730. PubMed ID: 33351265
[TBL] [Abstract][Full Text] [Related]
30. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
[TBL] [Abstract][Full Text] [Related]
31. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
32. Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver.
Aghemo A; Masarone M; Montagnese S; Petta S; Ponziani FR; Russo FP;
Dig Liver Dis; 2020 Sep; 52(9):937-941. PubMed ID: 32703730
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 and Cirrhosis: A Combination We Must Strive to Prevent.
Su F
Gastroenterology; 2021 Nov; 161(5):1371-1373. PubMed ID: 34453892
[No Abstract] [Full Text] [Related]
34. A local response to COVID-19 for advanced liver disease: Current model of care, challenges and opportunities.
Serper M; Shaked A; Olthoff KM; Hoteit M; Appolo B; Reddy KR
J Hepatol; 2020 Sep; 73(3):708-709. PubMed ID: 32450089
[No Abstract] [Full Text] [Related]
35. Liver injury in COVID-19 patients - a multidisciplinary experience and a call for national consensus.
Roman A; Georgescu AM; Moldovan S; Stoian M; Dobru D
J Gastrointestin Liver Dis; 2020 Dec; 29(4):688-690. PubMed ID: 33331346
[No Abstract] [Full Text] [Related]
36. Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID-19: A Multicenter Cohort.
Bajaj JS; Garcia-Tsao G; Wong F; Biggins SW; Kamath PS; McGeorge S; Chew M; Pearson M; Shaw J; Kalluri A; Fagan A; Olofson A; Moini M; de la Rosa Rodriguez R; Reddy KR
Liver Transpl; 2021 Sep; 27(9):1343-1347. PubMed ID: 33427401
[No Abstract] [Full Text] [Related]
37. Rare case of endogenous Klebsiella endophthalmitis associated with emphysematous prostatitis in a patient with diabetes, cirrhosis and COVID-19.
Crane AB; Abreu Diaz MC; Jiang Y; Pergament KM
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33883113
[TBL] [Abstract][Full Text] [Related]
38. Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis.
Grace JA; Casey S; Burrell LM; Angus PW
Hepatol Int; 2020 Sep; 14(5):884-885. PubMed ID: 32886332
[No Abstract] [Full Text] [Related]
39. Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19.
Lui DTW; Lee CH; Chow WS; Lee ACH; Tam AR; Fong CHY; Law CY; Leung EKH; To KKW; Tan KCB; Woo YC; Lam CW; Hung IFN; Lam KSL
J Clin Endocrinol Metab; 2021 Jan; 106(2):e926-e935. PubMed ID: 33141191
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of bilirubin and drug interactions.
Ng A
BMJ Open Gastroenterol; 2021 May; 8(1):. PubMed ID: 34006605
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
